These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8059336)

  • 1. Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55.
    Scheffel U; Kim S; Cline EJ; Kuhar MJ
    Synapse; 1994 Apr; 16(4):263-8. PubMed ID: 8059336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
    Hirano K; Kimura R; Sugimoto Y; Yamada J; Uchida S; Kato Y; Hashimoto H; Yamada S
    Br J Pharmacol; 2005 Mar; 144(5):695-702. PubMed ID: 15678084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
    Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
    Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
    Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
    Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
    Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB
    J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.
    Staley JK; Basile M; Flynn DD; Mash DC
    J Neurochem; 1994 Feb; 62(2):549-56. PubMed ID: 8294917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between [125I]RTI-55-labeled cocaine binding sites and the serotonin transporter in rat placenta.
    Shearman LP; McReynolds AM; Zhou FC; Meyer JS
    Am J Physiol; 1998 Dec; 275(6):C1621-9. PubMed ID: 9843724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
    Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytryptamine uptake complex. II. In vivo studies in rats.
    Biegon A; Mathis CA; Hanrahan SM; Jagust WJ
    Brain Res; 1993 Aug; 619(1-2):236-46. PubMed ID: 8374782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel serotonin transporter ligand: (5-iodo-2-(2-dimethylaminomethylphenoxy)-benzyl alcohol.
    Zhuang Z; Choi S; Hou C; Mu M; Kung M; Acton PD; Kung HF
    Nucl Med Biol; 2000 Feb; 27(2):169-75. PubMed ID: 10773546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    Caccia S; Anelli M; Codegoni AM; Fracasso C; Garattini S
    Br J Pharmacol; 1993 Sep; 110(1):355-9. PubMed ID: 7693282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
    Hirano K; Maruyama S; Kimura R; Kagawa Y; Yamada S
    Life Sci; 2004 Oct; 75(24):2933-45. PubMed ID: 15454344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and transporter binding properties of 3 beta-(4'-alkyl-, 4'-alkenyl-, and 4'-alkynylphenyl)nortropane-2 beta-carboxylic acid methyl esters: serotonin transporter selective analogs.
    Blough BE; Abraham P; Lewin AH; Kuhar MJ; Boja JW; Carroll FI
    J Med Chem; 1996 Sep; 39(20):4027-35. PubMed ID: 8831768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
    Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
    Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life.
    Wegerer V; Moll GH; Bagli M; Rothenberger A; Rüther E; Huether G
    J Child Adolesc Psychopharmacol; 1999; 9(1):13-24; discussion 25-6. PubMed ID: 10357514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.